10:00 am – 10:10 am: Pathologic Myopia and Its Complications. Quan V. Hoang, MD, PhD

10:10 am – 10:20 am: Photobiomodulation Treatment for Dry AMD: Pros and Cons. Glenn J. Jaffe, MD

10:20 am – 10:30 am: What We Know About Ang2 Blockade in Retinal Vascular Disease. Roger A. Goldberg, MD, MBA

10:30 am – 10:40 am: Proteomic Profile of Faricimab-Associated Occlusive Retinal Vasculitis. Alan Sherif, MD

10:40 am – 10:50 am: Survival Following Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy. Karen Wai, MD

10:50 am – 11:00 am: Gene Therapy for Wet AMD. Roger A. Goldberg, MD, MBA

11:00 am – 11:10 am: Dosing Blindly: Mitigating Inflammatory Responses in Gene Therapy via Volumetrics. David Almeida, MD, PhD, MBA

11:10 am – 11:20 am: Predictive Value of Infrared Imaging for the Area of Ellipsoid Zone Loss in Stargardt Disease. Amir Hariri, MD

11:20 am – 11:30 am: Panel discussion